Kenneth P Tercyak1, Beth N Peshkin, Lauren A Wine, Leslie R Walker. 1. Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007-2401, USA. tercyakk@georgetown.edu
Abstract
OBJECTIVES: Genetic tests for nicotine addiction susceptibility may someday offer preventive medicine specialists new tools to reduce smoking among adolescents. This paper examines adolescents' interest in, and reasons behind interest in, such testing and correlates of interest. METHODS: The sample included 211 healthy patients (ages 13-21) recruited from Georgetown University Medical Center's adolescent medicine clinic. Subjects completed a one-time behavioral survey immediately prior to or following a general medical check-up during calendar years 2001-2005. A 4-point self-report survey item served as the dependent variable. RESULTS: Sixty-two percent of adolescents were interested in genetic testing. Among the 72% of adolescents who provided a reason for their interest, 35% would find the information interesting for general or nonspecific reasons, 30% would find it personally useful, 8% noted it would be irrelevant, and 13% stated it would be unimportant; school performance and interest in cancer susceptibility testing were associated with interest in nicotine addiction susceptibility testing (adjusted r2 = 21%; P < 0.0001). CONCLUSIONS: Adolescent primary care patients will likely be receptive to comprehensive tobacco control programs incorporating genetic testing. Higher levels of educational achievement and greater interest in DNA-based preventive medicine may characterize those most interested. Offering testing will be contingent upon the development of safe and effective genetic tests.
OBJECTIVES: Genetic tests for nicotine addiction susceptibility may someday offer preventive medicine specialists new tools to reduce smoking among adolescents. This paper examines adolescents' interest in, and reasons behind interest in, such testing and correlates of interest. METHODS: The sample included 211 healthy patients (ages 13-21) recruited from Georgetown University Medical Center's adolescent medicine clinic. Subjects completed a one-time behavioral survey immediately prior to or following a general medical check-up during calendar years 2001-2005. A 4-point self-report survey item served as the dependent variable. RESULTS: Sixty-two percent of adolescents were interested in genetic testing. Among the 72% of adolescents who provided a reason for their interest, 35% would find the information interesting for general or nonspecific reasons, 30% would find it personally useful, 8% noted it would be irrelevant, and 13% stated it would be unimportant; school performance and interest in cancer susceptibility testing were associated with interest in nicotine addiction susceptibility testing (adjusted r2 = 21%; P < 0.0001). CONCLUSIONS: Adolescent primary care patients will likely be receptive to comprehensive tobacco control programs incorporating genetic testing. Higher levels of educational achievement and greater interest in DNA-based preventive medicine may characterize those most interested. Offering testing will be contingent upon the development of safe and effective genetic tests.
Authors: Denise M Scott; Evaristus Nwulia; John Kwagyan; Gloria Cain; Vanessa J Marshall; Nnenna Kalu; Altovise Ewing; Robert E Taylor Journal: Genet Test Mol Biomarkers Date: 2014-06-13
Authors: Linda J Herbert; Leslie R Walker; McKane E Sharff; Anisha A Abraham; Kenneth P Tercyak Journal: Int J Environ Res Public Health Date: 2010-04-14 Impact factor: 3.390
Authors: Marilyn Coors; Susan Mikulich-Gilbertson; Kristen Raymond; Shannon Stover; Thomas Crowley; Sandra Brown; Susan Tapert Journal: Am J Bioeth Date: 2008-10 Impact factor: 11.229
Authors: Maya Sabatello; Ying Chen; Carmen Fiorella Herrera; Erika Brockhoff; Jehannine Austin; Paul S Appelbaum Journal: Public Health Genomics Date: 2021-01-27 Impact factor: 2.000
Authors: Martijn D F Rhebergen; Maaike J Visser; Maarten M Verberk; Annet F Lenderink; Frank J H van Dijk; Sanja Kezic; Carel T J Hulshof Journal: J Community Genet Date: 2012-02-09
Authors: Margaret Berrigan; Jasmine Austrie; Aaron Fleishman; Kenneth P Tercyak; Martin R Pollak; Martha Pavlakis; Vinayak Rohan; Prabhakar K Baliga; Liise K Kayler; Thomas H Feeley; James R Rodrigue Journal: Am J Transplant Date: 2020-08-29 Impact factor: 8.086